logo
Select company
Select metric
0.75%Goodwill & Intangibles to Assets Ratio
VS
Market
38
Sector
52
Industry
72
History
-
$ 2.24Close
$ 1.52 - $ 4.53 52-Week Range
Ticker Information

Ticker

MREO

Company Name

MEREO BIOPHARMA GROUP PLC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MEREO BIOPHARMA GROUP PLC - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MREO - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 62.63M$ 470K0.75%
3/31/2025$ 68.32M$ 554K0.81%
12/31/2024$ 76.39M$ 643K0.84%
9/30/2024$ 88.75M$ 799K0.9%
6/30/2024$ 96.13M$ 866K0.9%
3/31/2024$ 55.94M$ 972K1.74%
12/31/2023$ 66.5M$ 1.09M1.64%
6/30/2023$ 100.8M$ 31.06M30.81%
12/31/2022$ 110.1M$ 30.14M27.38%
6/30/2022$ 135.04M$ 30.14M22.32%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MEREO BIOPHARMA GROUP PLC's latest trailing twelve months (TTM) Intang. to Assets stands at 50.28%.
  • Over the past 5 years, MEREO BIOPHARMA GROUP PLC's average Intang. to Assets has been 13.32%.
  • The median Intang. to Assets for MEREO BIOPHARMA GROUP PLC during this period was 1.74%
  • MEREO BIOPHARMA GROUP PLC reached its highest Intang. to Assets over the past 5 years at 50.28%.
  • The lowest Intang. to Assets recorded by MEREO BIOPHARMA GROUP PLC in the same timeframe 0.75%

MEREO BIOPHARMA GROUP PLC's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
CRDF : CARDIFF ONCOLOGY INC 0%ABEO : ABEONA THERAPEUTICS INC 0%HUMA : HUMACYTE INC 0%AVTX : AVALO THERAPEUTICS INC 8.3%COYA : COYA THERAPEUTICS INC 0%ABVC : ABVC BIOPHARMA INC 0%FDMT : 4D MOLECULAR THERAPEUTICS INC 0%VTGN : VISTAGEN THERAPEUTICS INC 0%ERNA : ERNEXA THERAPEUTICS INC 26.95%ANNX : ANNEXON INC 0%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for MEREO BIOPHARMA GROUP PLC is calculated as follows: Intangibles [ $ 39.56M ] / Assets [ $ 78.68M ]
(=) Intang. to Assets [ 50.28% ]

MREO - Goodwill & Intangibles to Assets Ratio, Last 5 years

0.75%

Minimum

Jun 30, 2025

50.28%

Maximum

Dec 31, 2020

13.32%

Average

1.74%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.98% with a standard deviation of 6.09%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.24K
min0%
max23.16%
average3.98%
median0.52%
std6.09%